v3.26.1
Consolidated Statements of Changes in Stockholders' Deficit - USD ($)
Common Stock [Member]
Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Additional Paid-in Capital [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Retained Earnings [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Total
Cumulative Effect, Period of Adoption, Adjustment [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Balance at Dec. 31, 2023 $ 22,000 $ (21,931) $ 69 $ 957,500 $ 21,931 $ 979,431 $ (1,467,361) $ (1,467,361) $ (487,861) $ (487,861)
Balance, shares at Dec. 31, 2023 11,000,000 (10,310,461) 689,539                  
Net loss             (1,309,872) (1,309,872)   (1,309,872)
Issuance of common stock         $ 257,645         $ 257,645
Issuance of common stock, shares 505                      
Balance at Dec. 31, 2024 $ 69     1,237,076     (2,777,233)     (1,540,088)    
Balance, shares at Dec. 31, 2024 690,044                      
Conversion of warrants $ 14     (14)            
Conversion of warrants, shares 143,393                      
Issuance of shares in Reverse Recapitalization $ 20     (4,602,596)         (4,602,576)    
Issuance of shares in Reverse Recapitalization, shares 209,101                      
Issuance of shares under working capital loans and non redemption agreements $ 14     14            
Issuance of shares under working capital loans and non redemption agreements, shares 138,424                      
Issuance of commitment fee shares under ELOC agreement $ 8     274,992         275,000    
Issuance of commitment fee shares under ELOC agreement, shares 75,326                      
Shares issued pursuant to settlement agreement $ 2     317,248         317,250    
Shares issued pursuant to settlement agreement, shares 15,625                      
Stock-based compensation $ 4     14,131,246         14,131,250    
Stock based compensation, shares 41,563                      
Conversion of convertible notes $ 222     9,523,461         9,523,683    
Conversion of convertible Notes, shares 2,219,932                      
Net loss         (24,480,848)     (24,480,848)    
Balance at Dec. 31, 2025 $ 353     $ 20,881,399     $ (27,258,081)     $ (6,376,329)    
Balance, shares at Dec. 31, 2025 3,533,408